Teva Pharmaceuticals USA Issues Statement on Affordable Medicines Utilization Act of 2011

NORTH WALES, Pa.--(BUSINESS WIRE)-- Teva commends Senators Scott Brown, Ron Wyden and John McCain for introducing the Affordable Medicines Utilization Act of 2011. As the largest provider of generic pharmaceuticals in the United States, Teva has been and continues to be committed to providing patients with access to the life-saving medicines they need. This legislation will encourage States to increase access to high-quality, low-cost pharmaceuticals for their Medicaid populations. At a time when State government officials are struggling to close their budget shortfalls, improving access to FDA approved generic medicines will help lower their health care costs while maintaining access to care.



CONTACT:

Teva Pharmaceuticals
Denise Bradley, 215-591-8974
[email protected]

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Health  Public Policy/Government  Healthcare Reform  Pharmaceutical

MEDIA:

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.